Recently, the Korean Food and Drug Administration approved the PNA ClampTMEGFR Mutation Detection kit (PANAGENE Inc., Daejeon, Korea) as a standard screening method for EGFR mutation in lung cancer patients [21, 22]. This evidence concerns the gene EGFR and lung carcinoma.